The efficacy and safety of nivolumab in previously treated advanced non-small-cell lung cancer: a meta-analysis of prospective clinical trials

BACKGROUND: Nivolumab (BMS-936558/ONO-4538) was the first monoclonal antibody targeting programmed death (PD)-1. So far, a number of clinical trials on nivolumab have showed satisfactory efficacy in treating non-small-cell lung cancer (NSCLC). Herein, we present a meta-analysis evaluating the effica...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Onco Targets Ther
Main Authors: Huang, Jiaxing, Zhang, Yaxiong, Sheng, Jin, Zhang, Hongyu, Fang, Wenfeng, Zhan, Jianhua, Zhou, Ting, Chen, Ying, Liu, Lin, Zhang, Li
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2016
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5045236/
https://ncbi.nlm.nih.gov/pubmed/27713640
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S115262
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados